OrbiMed’s Adicet Bio ACET Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$6.98M	Hold	11,447,140	–	–	0.17%	68
2025 Q1	$8.64M	Hold	11,447,140	–	–	0.21%	64
2024 Q4	$11M	Hold	11,447,140	–	–	0.23%	69
2024 Q3	$16.5M	Hold	11,447,140	–	–	0.3%	71
2024 Q2	$13.9M	Hold	11,447,140	–	–	0.27%	65
2024 Q1	$26.9M	Buy	11,447,140 +3,125,000	+38%	+$7.34M	0.49%	56
2023 Q4	$15.7M	Hold	8,322,140	–	–	0.31%	68
2023 Q3	$11.4M	Hold	8,322,140	–	–	0.24%	78
2023 Q2	$20.2M	Buy	8,322,140 +875,000	+12%	+$2.13M	0.37%	70
2023 Q1	$42.9M	Hold	7,447,140	–	–	0.84%	40
2022 Q4	$66.6M	Hold	7,447,140	–	–	1.27%	27
2022 Q3	$106K	Sell	7,447,140 -1	-0%	–	1.97%	14
2022 Q2	$109K	Hold	7,447,141	–	–	1.97%	15
2022 Q1	$149M	Hold	7,447,141	–	–	2.41%	10
2021 Q4	$130M	Buy	7,447,141 +214,285	+3%	+$3.75M	1.67%	19
2021 Q3	$56.7M	Hold	7,232,856	–	–	0.62%	48
2021 Q2	$74.4M	Hold	7,232,856	–	–	0.75%	44
2021 Q1	$94.6M	Buy	7,232,856 +524,349	+8%	+$6.86M	0.88%	33
2020 Q4	$94.3M	Hold	6,708,507	–	–	0.82%	36
2020 Q3	$79.8M	Buy	6,708,507 +1,878,120	+39%	+$22.3M	1%	29
2020 Q2	$10.4M	Hold	4,830,387	–	–	0.15%	97
2020 Q1	$4.98M	Hold	4,830,387	–	–	0.08%	103
2019 Q4	$7.2M	Hold	4,830,387	–	–	0.1%	88
2019 Q3	$42.7M	Hold	4,830,387	–	–	0.81%	40
2019 Q2	$49.3M	Hold	4,830,387	–	–	0.76%	40
2019 Q1	$32.9M	Hold	4,830,387	–	–	0.51%	53
2018 Q4	$41.6M	Hold	4,830,387	–	–	0.77%	42
2018 Q3	$73.1M	Hold	4,830,387	–	–	0.88%	33
2018 Q2	$44.2M	Hold	4,830,387	–	–	0.53%	55
2018 Q1	$46.3M	Buy	+4,830,387	New	+$46.3M	0.57%	52